Effect of Hydrocortisone on Development of Shock Among Patients With Severe SepsisDidier Keh, Holger Bogatsch, Josef Briegel et al.|JAMA|2016Cited by 265
Effect of Sodium Selenite Administration and Procalcitonin-Guided Therapy on Mortality in Patients With Severe Sepsis or Septic ShockFrank Bloos, Evelyn Trips, Axel Nierhaus et al.|JAMA Internal Medicine|2016Cited by 259
The use of mid-regional proadrenomedullin to identify disease severity and treatment response to sepsis - a secondary analysis of a large randomised controlled trialPatrick Meybohm, Gunnar Elke, Frank Bloos et al.|Critical Care|2018Cited by 119
Current clinical use of intravenous fosfomycin in ICU patients in two European countriesChristian Putensen, F.-A. Litty, Björn Ellger et al.|Infection|2019Cited by 63
Efficacy and Safety of Vilobelimab (IFX-1), a Novel Monoclonal Anti-C5a Antibody, in Patients With Early Severe Sepsis or Septic Shock—A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase IIa Trial (SCIENS Study)Michael Bauer, A. Weyland, Gernot Marx et al.|Critical Care Explorations|2021Cited by 36